The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey

Abstract

The WERF EndoCost study is funded by the World Endometriosis Research Foundation (WERF) through grants received from Bayer Schering Pharma AG, Takeda Italia Farmaceutici SpA, Pfizer Ltd and the European Society of Human Reproduction and Embryology. The sponsors did not have a role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript. L.H. is the chief executive and T.D. was a board member of WERF at the time of funding. T.D. holds the Merck-Serono Chair in Reproductive Medicine and Surgery, and the Ferring Chair in Reproductive Medicine at the Katholieke Universiteit Leuven in Belgium and has served as consultant/research collaborator for Merck-Serono, Schering-Plough, Astellas and Arresto.

Clinical Efficacy of Levonorgestrel Releasing Intrauterine System for the Treatment of Adenomyosis in Perimenopausal Women

“…The results indicated that the quality of adenomyosis patient's life was significantly improved after LNG-IUS insertion. the SF-36-based survey has been used among 931 women with endometriosis treated in 12 tertiary care centers in 10 countries that investigated the effect of endometriosis on education, work and social wellbeing, endometriosis -associated symptoms and health-related quality of life [23], and also used to types and frequency of digestive symptoms in patients with different localizations of pelvic endometriosis and which specific symptoms are related to rectal stenosis [24]. To the best of our knowledge, this Note: Continuous variables are expressed as mean ± standard deviation; Paired-samples t test as appropriate; a P < 0.001 vs before treatment, b P < 0.001 vs after 1 month, c P < 0.001 vs after 6 months.…”

Systematic Review of Prevalence of Endometriosis among Indigenous Africans

“…The estimated prevalence of endometriosis among in the women of reproductive age is between 2% and 10% [6]. Chronic pelvic pain and dyspareunia are two clinical presentation of endometriosis with a major impact on physical and mental constituents of quality of life [7]. The onset of symptoms of the endometriosis and its surgical diagnosis has a diagnostic delay of 6.7 years [8].…”

“…The onset of symptoms of the endometriosis and its surgical diagnosis has a diagnostic delay of 6.7 years [8]. Endometriosis is a true chronic disease with a significant impairment of quality of life due to endometriosis-associated symptoms (chronic pelvic pain, dysmenorrhoe, dyspareunia and infertility) even when the management of the disease is in a tertiary centre [7]. Endometriosis is connected to discomfort/pain, anxiety/depression and social dysfunction, which affect health related quality of life.…”

Mulheres com dor pélvica crônica possuem desempenho físico inferior ao de mulheres saudáveis

“…Além da carga de desconforto físico, muitas vezes há o comprometimento da qualidade de vida (DE GRAAFF et al, 2013;), maior probabilidade de morbidade psicológica (LORENCATTO et al, 2006;LUZ et al, 2014;GERRITS et al, 2015), função física prejudicada, alto impacto socioeconômico, familiar e matrimonial. Além dos altos custos financeiros, já que, as despesas médicas diretas estimadas para consultas ambulatoriais para a DPC nos Estados Unidos, em mulheres com idade entre 18 a 50 anos, variam de U$ 881.500.000 à U$2,8 bilhões por ano .…”

“…A condição pode comprometer a capacidade para executar determinadas tarefas físicas, seja pela própria dor, A prevalência de mulheres com DPC varia de 3,8 a 19% (ZONDERVAN et al, 1999;COELHO et al, 2014). A esse índice elevado somamse muitos efeitos negativos, como o desconforto físico, o comprometimento da qualidade de vida (DE GRAAFF et al, 2013;, maior probabilidade de morbidade psicológica (LORENCATTO et al, 2006;LUZ et al, 2014;GERRITS et al, 2015), função prejudicada, alto impacto socioeconômico , familiar e matrimonial.…”